Legacy Wealth Asset Management LLC Sells 115 Shares of Encompass Health Co. (NYSE:EHC)

Legacy Wealth Asset Management LLC decreased its stake in Encompass Health Co. (NYSE:EHC) by 1.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,353 shares of the company’s stock after selling 115 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Encompass Health were worth $643,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the company. Parallel Advisors LLC lifted its stake in Encompass Health by 25.0% in the 1st quarter. Parallel Advisors LLC now owns 2,319 shares of the company’s stock valued at $235,000 after purchasing an additional 464 shares during the last quarter. GAMMA Investing LLC lifted its stake in Encompass Health by 12,207.6% in the 1st quarter. GAMMA Investing LLC now owns 239,628 shares of the company’s stock valued at $24,270,000 after purchasing an additional 237,681 shares during the last quarter. Versant Capital Management Inc lifted its stake in Encompass Health by 390.7% in the 1st quarter. Versant Capital Management Inc now owns 1,737 shares of the company’s stock valued at $176,000 after purchasing an additional 1,383 shares during the last quarter. 111 Capital acquired a new stake in Encompass Health in the 4th quarter valued at about $502,000. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in Encompass Health by 46.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 19,204 shares of the company’s stock valued at $1,774,000 after purchasing an additional 6,053 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on EHC shares. UBS Group raised their target price on shares of Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a research note on Monday, April 28th. Royal Bank of Canada raised their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research report on Monday, April 28th. Truist Financial restated a “buy” rating and set a $135.00 price objective (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Wall Street Zen upgraded shares of Encompass Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 24th. Eight equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $122.71.

Encompass Health Stock Up 0.8%

NYSE EHC opened at $121.01 on Monday. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 1-year low of $82.74 and a 1-year high of $122.09. The company has a 50 day moving average of $109.93 and a 200-day moving average of $102.01. The company has a market cap of $12.20 billion, a price-to-earnings ratio of 27.13, a PEG ratio of 2.31 and a beta of 0.91.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company’s revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.12 earnings per share. On average, equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. Encompass Health’s dividend payout ratio is currently 14.05%.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 118,384 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the completion of the transaction, the chief executive officer now directly owns 527,070 shares of the company’s stock, valued at $64,054,817.10. This represents a 18.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares of the company’s stock, valued at $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock valued at $16,034,082 over the last three months. Corporate insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.